In attempts to find a prescreen for mutagens that may induce heritable mutations in mammals, an in vivo somatic mutation test has been developed in the mouse that uses a localized gene product (hair pigment), is relatively fast and cheap, and gives results that have some predictive value for point mutation induction in spermatogonia. Embryos heterozygous at specific coat color loci are exposed to the presumptive mutagen, and 3 weeks later the fur is observed for spots of altered color. It is possible to distinguish spots resulting from expression of the recessive (RS's) from spots having various other causes.
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In tests with seven compounds, mutation rates per locus and unit dose have been calculated on the assumption that 175 cells are at risk per 101/4-day embryo (a number derived from distribution of spot proportions). These rates are found to be roughly parallel to, but uniformly higher than spermatogonial point-mutation rates for the same seven compounds. The higher somatic rates are presumably due to the fact that RS's can result from several genetic mechanisms besides point mutations. The spot test, which has not to date given any false negatives, may thus be considered a useful in vivo prescreen for heritable germinal mutations in mammals.
Despite the recent proliferation in development of submammalian and in vitro test systems for mutagenic studies, there is general agreement that in vivo studies on heritable genetic effects in mammals must, at some stage, enter into the risk evaluation for compounds that show a potential for affecting human populations. Since such testing can, however, be relatively time-and space-consuming, it must be reserved for only selected possible mutagens.
For this reason, some effort has been devoted to the perfection of an in vivo mammalian somaticmutation test that might be capable of acting as a prescreen for germinal mutations of various kinds. This test was first developed by us in an x-ray experiment about 20 years ago and, at that time, explored for its various-complexities (1). The usefulness of the method in chemical mutagenesis has been tested more recently (2) (3) (4) (5) (6) (7) (8) (9) . We have elsewhere presented some of our recent results in some detail (3), have discussed some of the more basic aspects of the method (9) , and have compared the interpretations various investigators have made of their data (9) . For the purposes of this symposium, some of *Biology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830. the findings will be summarized, and the relation between somatic and germinal mutation rates explored.
In a germinal mutation experiment, each individual examined for presence or absence of a whole-body mutation scores one cell that was at risk to the mutagen. In an in vivo somatic mutation experiment, an individual is examined, instead, for clones of mutant cells (Fig. 1) . While each clone again represents just one cell at risk, the whole irndividual represents a population of cells at risk-an obvious advantage in numbers. It should be noted, however, that the altered clone (consisting, as it does, of somatic cells) cannot ordinarily be involved in breeding tests, so that the nature of the genetic event that produced it cannot be genetically analyzed.
The method as originally developed (1) meets the following prerequisites of a successful somatic mutation prescreen: it uses a localized gene product (namely hair pigment) so that clones of exceptional cells can be directly identified; it involves an in vivo mammalian situation; and it is relatively fast and cheap. In addition, as more recently demonstrated, the results have predictive value for germinal point mutations (3, 9) .
The in vivo somatic mutation test consists of treating embryos (i.e., populations of cells) that are 
